Aclaris Therapeutics, Inc.
ACRS· Nasdaq
ACRSAclaris Therapeutics, Inc.
Filed Mar 15, 2017 · 10-K · 74 days after period end · 0001558370-17-001802
| Metric | Q4 2016 | Q4 2015 | Q4 2014 |
|---|---|---|---|
| Net Income | -$11.48M | -$4.71M | -$2.60M |
| EPS Diluted | -$0.49 | -$0.28 | -$1.76 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Aclaris Therapeutics, Inc. · CIK 1557746 · Engraved from SEC EDGAR
ended Dec 31, 2016 · filed Mar 15, 2017 · 74 d after period end
